Lankau New CEO at Logical

Xconomy Boston — 

Logical Therapeutics, a Waltham, MA-based developer of drugs to treat inflammation, says that Peter Lankau has been named CEO of the company, according to a press release. Lankau was previously CEO of Endo Pharmaceuticals (NASDAQ:ENDP), a specialty drug firm headquartered in Chadds Ford, PA. Rebecca caught up the Logical in late 2007 and detailed how Logical plans to develop a new compound that turns into anti-inflammation drug naproxen in the bloodstream.